Cho HS, Choo YK, Lee HJ, Lee HS. Transient carnitine transport defect with cholestatic jaundice: report of one case in a premature baby.
KOREAN JOURNAL OF PEDIATRICS 2012;
55:58-62. [PMID:
22375151 PMCID:
PMC3286764 DOI:
10.3345/kjp.2012.55.2.58]
[Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 06/28/2011] [Revised: 09/05/2011] [Accepted: 09/28/2011] [Indexed: 12/30/2022]
Abstract
Carnitine (β-hydroxy-γ-trimethylaminobutyric acid) is involved in the transport of long-chain fatty acids into the mitochondrial matrix and the removal of potentially toxic acylcarnitine esters. Transient carnitine transport defect is a rare condition in newborns reported in 1/90,000 live births. In this paper, we describe a case of transient carnitine transport defect found in a premature baby who had prolonged cholestatic jaundice and poor weight gain, and who responded dramatically to oral carnitine supplementation.
Collapse